Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients … CU Correll, M Solmi, N Veronese, B Bortolato, S Rosson, P Santonastaso, ... World Psychiatry 16 (2), 163-180, 2017 | 1627 | 2017 |
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness J Firth, N Siddiqi, AI Koyanagi, D Siskind, S Rosenbaum, C Galletly, ... The Lancet Psychiatry 6 (8), 675-712, 2019 | 1285 | 2019 |
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ... American Journal of Psychiatry 174 (3), 216-229, 2017 | 1027 | 2017 |
Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta‐analysis D Vancampfort, J Firth, FB Schuch, S Rosenbaum, J Mugisha, M Hallgren, ... World Psychiatry 16 (3), 308-315, 2017 | 922 | 2017 |
Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis D Vancampfort, CU Correll, B Galling, M Probst, M De Hert, PB Ward, ... World Psychiatry 15 (2), 166-174, 2016 | 725 | 2016 |
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study M Di Forti, A Marconi, E Carra, S Fraietta, A Trotta, M Bonomo, F Bianconi, ... The Lancet Psychiatry 2 (3), 233-238, 2015 | 678 | 2015 |
EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA … B Stubbs, D Vancampfort, M Hallgren, J Firth, N Veronese, M Solmi, ... European Psychiatry 54, 124-144, 2018 | 643 | 2018 |
Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis JA Udell, R Zawi, DL Bhatt, M Keshtkar-Jahromi, F Gaughran, ... Jama 310 (16), 1711-1720, 2013 | 620 | 2013 |
Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users M Di Forti, H Sallis, F Allegri, A Trotta, L Ferraro, SA Stilo, A Marconi, ... Schizophrenia bulletin 40 (6), 1509-1517, 2014 | 589 | 2014 |
How much physical activity do people with schizophrenia engage in? A systematic review, comparative meta-analysis and meta-regression B Stubbs, J Firth, A Berry, FB Schuch, S Rosenbaum, F Gaughran, ... Schizophrenia research 176 (2-3), 431-440, 2016 | 406 | 2016 |
Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies J Lally, O Ajnakina, B Stubbs, M Cullinane, KC Murphy, F Gaughran, ... The British Journal of Psychiatry 211 (6), 350-358, 2017 | 374 | 2017 |
How sedentary are people with psychosis? A systematic review and meta-analysis B Stubbs, J Williams, F Gaughran, T Craig Schizophrenia research 171 (1-3), 103-109, 2016 | 357 | 2016 |
Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses J Lally, O Ajnakina, M Di Forti, A Trotta, A Demjaha, A Kolliakou, ... Psychological medicine 46 (15), 3231-3240, 2016 | 315 | 2016 |
An examination of polygenic score risk prediction in individuals with first-episode psychosis E Vassos, M Di Forti, J Coleman, C Iyegbe, D Prata, J Euesden, P O’Reilly, ... Biological psychiatry 81 (6), 470-477, 2017 | 250 | 2017 |
Can high-intensity interval training improve physical and mental health outcomes? A meta-review of 33 systematic reviews across the lifespan R Martland, V Mondelli, F Gaughran, B Stubbs Journal of sports sciences 38 (4), 430-469, 2020 | 234 | 2020 |
The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of … D Vancampfort, J Firth, CU Correll, M Solmi, D Siskind, M De Hert, ... Focus 19 (1), 116-128, 2021 | 225 | 2021 |
Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder F Gaughran, J Payne, PM Sedgwick, D Cotter, M Berry Brain research bulletin 70 (3), 221-227, 2006 | 220 | 2006 |
The interface of physical and mental health AM Doherty, F Gaughran Social psychiatry and psychiatric epidemiology 49, 673-682, 2014 | 208 | 2014 |
The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: a systematic review and meta-analysis B Stubbs, D Vancampfort, N Veronese, M Solmi, F Gaughran, P Manu, ... Journal of affective disorders 197, 259-267, 2016 | 201 | 2016 |
Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: a systematic review and meta-analysis J Lally, J Tully, D Robertson, B Stubbs, F Gaughran, JH MacCabe Schizophrenia research 171 (1-3), 215-224, 2016 | 185 | 2016 |